Michael Berg
General Counsel bei TEARLAB CORPORATION
Profil
Michael Berg is currently the Vice President-Regulatory at TearLab Corporation, Inc. since 2006 and the President at Hemocue, Inc. since 2013.
He completed his undergraduate degree at the University of Notre Dame.
Aktive Positionen von Michael Berg
| Unternehmen | Position | Beginn |
|---|---|---|
| TEARLAB CORPORATION | General Counsel | 01.01.2006 |
| Hemocue, Inc. | Präsident | 20.05.2010 |
Ausbildung von Michael Berg
| University of Notre Dame | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
TearLab Corporation, Inc.
 TearLab Corporation, Inc. Medical SpecialtiesHealth Technology TearLab Corporation, Inc. engages in the development and marketing of a tear testing platform. Its primary product, the TearLab Osmolarity System, enables eye care practitioners to test for highly sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. It measures tear film osmolarity for the diagnosis of dry eye disease. The company was founded by Benjamin D. Sullivan in 1996 and is headquartered in Escondido, CA. | Health Technology |
| Hemocue, Inc. |
